Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA)

CAPS Rating: 2 out of 5

The Company is engaged in the discovery and development of breakthrough medicines to treat cancers by regulating cell signaling with small molecules.

Recs

0
Player Avatar phatchips767 (< 20) Submitted: 5/21/2011 2:06:32 PM : Outperform Start Price: $8.59 ARIA Score: +94.04

pe of 14. One of the big monkees i watch likes it.

Report this Post 1 Comment
Member Avatar MegaShort (99.96) Submitted: 6/20/2011 6:03:37 PM
Recs: 0

You realize that was 1 time revenue, and trailing earnings are about to go back below 0, right?

Report this Post

Featured Broker Partners


Advertisement